HER2 (c-erbB-2) Rabbit Polyclonal Antibody (clone Z4881), Concentrate - Citations

HER2 (c-erbB-2) Rabbit Polyclonal Antibody (clone Z4881), Concentrate - Citations

View additional product information for HER2 (c-erbB-2) Rabbit Polyclonal Antibody (clone Z4881), Concentrate - Citations (280004)

Showing 4 product Citations

Citations & References
Abstract
Human ErbB-2 (Her-2) transgenic mice: a model system for testing Her-2 based vaccines.
AuthorsPiechocki MP, Ho YS, Pilon S, Wei WZ,
JournalJ Immunol
PubMed ID14634087
'Her-2 transgenic (Tg) mice were generated with wild-type human c-ErbB-2 (Her-2) under the whey acidic protein promoter. They are tolerant to Her-2 and appropriate for testing Her-2 vaccines. The expression of transmembrane ErbB-2 from the whey acidic protein-Her-2 cassette and its up-regulation by insulin and hydrocortisone was verified by in ... More
AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
AuthorsTraxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G,
JournalCancer Res
PubMed ID15256466
Aberrant epidermal growth factor receptor (EGFR) and ErbB2 expression are associated with advanced disease and poor patient prognosis in many tumor types (breast, lung, ovarian, prostate, glioma, gastric, and squamous carcinoma of head and neck). In addition, a constitutively active EGFR type III deletion mutant has been identified in non-small ... More
Evaluation of prognostic factors in male breast cancer.
AuthorsTemmim L, Luqmani YA, Jarallah M, Juma I, Mathew M
JournalBreast
PubMed ID14965580
We conducted an analysis on 41 cases of male breast cancer (median age 54 y; range 25-82 y) in Kuwait. Most (51%) were stage II cancers with 65% arising in the left breast. There were 5 (12%) T1 tumours, 23 (56%) T2 tumours and 13 (32%) T3/T4 tumours. They were ... More
In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
AuthorsKommoss F, Colley M, Hart CE, Franklin WA
JournalMol Cell Probes
PubMed ID1969111
An increasing body of evidence suggests that breast tumour growth is mediated by oncogene products and growth factors which are or which act through cell surface receptors. The aims of the present study were to determine how three of these receptors, c-erbB-2 protein, epidermal growth factor receptor (EGFr) and the ... More